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  ABSTRACT 
Environmental Pollution is the one of the major problem of the hour. In this fast 
moving scenario, pollution both industrial and air plays a major role in affecting 
living beings. These pollutants mainly consist of mainly organic pollutants and 
particulate matter. Polycyclic Aromatic Hydrocarbons (PAH) are the groups of 
organic pollutants that are ubiquitously present, resistant to degradation and can 
stay for a longer time in the atmosphere.They are known as mutagen, 
carcinogen and tetratogen. One such PAH is Benzo[a]pyrene, which is first pro-
carcinogen to be discovered which causes skin cancer and respiratory problems 
etc. Benzo[a]pyrene is a five membered ring which is basically produced from 
incomplete combustion of fossil fuels, exhaust from automobiles and industries. 
The toxicity of Benzo[a]pyrene is the result of bioactivation of B[a]P to 
diolepoxides by monooxygenase enzymes i.e. CYP450 enzyme systems in 
human body. Diol epoxides are DNA adducts which mutate the p53 tumor 
suppressor gene leads to tumor. Hence these enzymes are inhibited by active 
compounds extracted from Black tulsi. They are eugenol, carvacrol, elemene, 
caryophyllene and linalool. In this study we have reported that active 
compounds of tulsi bind to cytochrome P450 enzyme active site and inhibit 
those from binding benzo[a]pyrene. By docking studies done in Hex software 
has proved that active compounds of tulsi bind to CYP450. Also not only in- 
silico studies but also in-vitro analysis like MTT assay, DAPI staining and 
EROD assay was done to confirm our topic. 
Keywords: particulate matter, benzo[a]pyrene, CYP450, Tulsi 
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INTRODUCTION 
Pollution is the major problem of the today‘s first moving industrialization and 
globalization .Air Pollution plays a major role in affecting human health as well 
as environment. The hazardous chemicals producing from the industries, 
transportation and burning of fossil fuels are the major air pollutant causing 
various diseases to human being and other organisms. Air pollutants are mainly 
gases.The pollutants include gaseous substances such as sulphur oxide, nitrogen 
dioxide, and carbon monoxide, particulate matter including organic, inorganic 
matter, nitrogen compounds, sulphur compounds, polycyclic aromatic 
hydrocarbons (PAHs), several heavy metals, and radio nuclides. Air polluting 
industries include thermal power plants, iron and steel plants, smelters, 
foundries, stone crushers, cement plants, refineries, shoe industry, plastic 
industry, chemicals and petrochemical plants. The main source of gaseous 
pollutants are from  incomplete burning of fossil fuels, (Kampa et al, 2007) next 
is automobiles and air from chimneys of factories. The second pollutants are the 
Organic pollutants. They form a toxic group of chemicals which persist for a 
long interval of time in the environment.Their effects are amplified as they 
move up through the food chain which include pesticides, dioxin and furans. 
(Schecter et al, 2006). Dioxins are those substances which are formed during 
incomplete combustion and materials containing chlorine (e.g. plastics). Most 
dioxins are present in plants are from air or pesticides and these enter the food 
chain where they accumulate due to their ability of binding to lipids. The third 
groups of pollutants are Particulate Matter which consists of complex and 
varying mixturesof particles suspended in the air, which vary in size and 
composition. They are produced by a variety ofnatural and anthropogenic 
activities (Poschl et al, 2005). Major sources are from factories, atomic power 
plants, refuse incinerators, motor vehicles, construction sites, firesand natural 
windblown dust. The size of the particles varies from 2.5-10 microns for 
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aerodynamic diameter smaller than2.5mm and 10mm respectively (Kampa et al, 
2007). Some other pollutants are heavy metals like arsenic, cadmium, lead, 
chromium, copper; nickel, selenium and zinc are emitted from combustion and 
industrial activities like metals works and smelters. The composition of PM 
varies, as they can absorb and transfer a multitude of pollutants. In addition, the 
metal content, the presence of PAHs and other organic components such as 
endotoxins, mainly contribute to PM toxicity (Knaapen, et al., 2002). Benzo 
[a]pyrenewhich is one of the priority pollutant, heavy metals can reside in or be 
attached to the particulate matter. The last pollutants are known to be Volatile 
Organic Compounds. It consists of polycyclic aromatic hydrocarbon. These 
compounds are as follows: Naphthalene, acenaphthylene, fluorene, anthracene, 
fluoranthene, chrysene, benzo[a]pyreneand dibenzo (a, h) anthracene. The high 
mortality indicates by skin and lung cancers are the most notable examples of 
the carcinogenic potential of PAH compounds. (Mastral et al, 2000)Polycyclic 
Aromatic Hydrocarbonsare fused aromatic rings and do not contain heteroatom. 
Naphthalene is the simplest example. PAHs occur in oil, coal, and tar deposits, 
are produced as byproducts of fuel burning. They are potent atmospheric 
pollutants. Some compounds have identified as carcinogenic and mutagenic. 
PAHs are also found in cooked foods for such as in barbecuing and in smoked 
fish. Our research interest is on Benzo[a]pyrenewhich is a PAH compound 
produced from incomplete combustion of coal tar, cigarette smoke, charbroiled 
food and automobile exhausts at 300 -600 degree Celsius. Its metabolite are 
highly mutagenic and carcinogenic and is listed in group 1(Carcinogens to 
human) by the IARC (International Agency for Research on Cancer). In early 
period the chimney sweepers suffered from scrotal and skin cancer in 18th -19th 
century.Benzo[a]pyrene found in tobacco smoke was shown to cause genetic 
damage in lung cells that was identical to the damage observed in the DNA of 
most malignant lung tumors. (Denissenko et al, 1996)A study proved that 
Benzo[a]pyrene is not carcinogenic instead benzo[a]pyrene is activated to a 
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DNA adduct substance called benzo[a]pyrene -7, 8-dihydrodiol-9, 10-epoxide 
which is activated by a group of metabolizing enzymes of our body known as 
cytochromeP450 enzyme system specially CYP450 1B1 group. 
The cytochrome P450 super family of monooxygenases (CYP) is a large group 
of enzymes that metabolize the oxidation of organic substances. Substrates of 
CYP enzymes include metabolic intermediates such 
as lipids and steroidal hormones and xenobiotic compounds such as drugs 
and toxic chemicals. CYPs are major enzymes involved in drug metabolism and 
bioactivation, accounting for about 75% of the total number of metabolic 
reactions. (Guengerich et al, 2008)Benzo[a]pyrene is a procarcinogen that is 
converted to carcinogen. The mechanism is that benzo[a]pyrenediolepoxide, 
molecule intercalate in DNA, covalently bonding to the guanine nucleobases. It 
disrupts the process of replication and induces mutations, which lead 
to cancer after exposure. There are indications that benzo[a]pyrenediol epoxide 
specifically targets the protective p53 gene. (Pfeifer et al, 2002)This gene 
functions as a tumor suppressor. By inducing G (guanine) to T 
(thymidine) transversions, there is a probability that benzo[a]pyrenediol 
epoxide inactivates the tumor suppression ability in certain cells, leading to 
cancer and mainly skin cancer. The cytochromesP450 enzymes constitute a 
super family of heme-containing enzymes that catalyze the metabolism of a 
variety of xenobiotic compounds. This is a series of steps in which activation of 
molecular oxygen by the heme group and a process involving the delivery of 
two electrons to the P450 system followed by cleavage of the dioxygen bond, 
producing water and an activated iron-oxygen species which reacts with 
substrates through a various mechanisms. Therefore in order to suppress the 
activity of these enzymes, we have found drugs to inhibit the activity of 
enzymes from Tulsi (blackTulsi specifically). Tulsi scientifically named as 
Ocimumtenuiflorum.It is an aromatic plant of the family Lamiaceae and native 
plant of south Asia. The plant is erect, shrub, much branched with hairy stems 
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and green or purple leaves that are strongly scented. We have introspected the 
active compounds present in Tulsi e.g. eugenol, caryophyllene, carvacrol, 
elemene, linalool and others which help to reduce the benzo[a]pyrene 
cytotoxicity. The enzymes CYP1B1 specially, will get inhibited and it cannot 
further activate benzo[a]pyrene and it will be excreted as such without 
converting into harmful carcinogen. In our present studies we have generated 
results throughin-vitro as well as computational studies which have concluded 
that Tulsi‘s active compounds help in reducing the cytotoxicity by 
Benzo[a]pyrene. The active compounds inhibit CYP450 enzymes from binding 
to Benzo[a]pyrene, instead the active compounds bind to CYP450 active site 
and inhibit the activation. We have proved our statement by both in-vitro and 
in-silicoanalysis. 
In this report, we have studied in-silico studies first to figure out the binding 
sites of Tulsi’s compounds with CYP450 enzymes by docking studies. The 
binding sites were then confirmed using in-vitro studies like MTT assay, DAPI 
staining, Thin liquid layer chromatography, NMR and EROD Assay. 
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REVIEW OF LITERATURE 
The human body is bombarded with diversity of xenobiotics, both from natural 
and anthropogenic sources. Xenobiotics are the foreign substances to the human 
body and only can enter from external sources like antibiotics. The vast 
majority of xenobiotics that find their way into the human body are naturally 
occurring   phytochemicals, few areman-made chemicals have received most 
attention, since the focus of regulation is largely confined to these. The 
bodyrecognizes the xenobiotics as foreign, potentially harmfulto its survival, 
and   response is to protect. Humans as well as animals have potential to remove 
these xenobiotics from the body by a complex set of enzymes. A number of 
enzyme systems, capable of metabolizing xenobiotics have been identified and 
extensively investigated, the most important enzyme system is thecytochrome 
P450-dependent mixed-function oxidases, aubiquitous system of haem-thiolate 
enzymes encountered inalmost every human organ, but with the 
highestconcentration in the liver, which consequently functions asthecentre of 
xenobiotic metabolism, being capable ofcatalyzing both oxidation and reduction 
pathways. 
BENZO [A] PYRENE AFFECTS HUMAN HEALTH:  
The main potent agent causing adverse effect in humans is benzo[a]pyrene-7, 8-
diol-9, 10-epoxide which is formed from the activation of benzo[a]pyrene. The 
cytotoxicity depends upon the place and route of exposure of this hazardous 
metabolite. Its main exposure sites may be by inhalation, ingestion and surface 
exposures on skin. This results in formation of tumor at the site of exposure like 
skin tumor, rashes, skin irritation, lung tumor and liver tumor. Non- 
carcinogenic compounds like B[a]P which if absorbed for a long duration and 
multiple times results in enhancing its carcinogenic ability. Oral exposure to this 
compound causes sterility in progeny after mother is exposed to it and 
developmental deformality in reduced fetus weight and death at later stage. The 
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oral exposure to mice has confirmed the above mentioned cases. It causes 
adenomas and papillomas when exposed through intragastric way for duration 
of three months. The carcinogenic dose was 33.3mg/kg/day. Warts and skin 
eruptions were reported by the dermal exposure ofBaP for 1 to 3 months. 
(http://www.environment.alberta.ca/) 
CYTOCHROMEP450 
NAMING SYSTEM OF THE ENZYME: 
Gene coding for cytochrome enzymes are denoted as CYP, and CYP1B1 means 
of family 1, and subfamily B and the polypeptide chain is 1. 
 
HISTORY OF CYTOCHROMES 
Cytochromes P450 were found from the first experiment conducted by Axelrod 
and Brodie in the year 1955 .They identified the enzymes which were 
Fig1. Nomenclature of the enzyme 
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responsible to oxidize xenobiotic compounds in the smooth ER of their liver. 
(Garfinkel et al, 1958) Another scientist Garfinkel and Klingenberg discovered 
that a CO binding pigment present in liver microsomes.(Omura and Sato et 
al,1964).These had an absorption spectra at 450nm which was named as 
Cytochrome P450.(Omura& Sato et al,1964) P450 is a low spin ferric heme 
containing proteins with a thiol residue as an heme ligand. (Bayer et al, 1969) 
 
 
 
 
STRUCTURE OF CYTOCHROME P450  
They contain an iron heme cofactor. The centre containing iron is bonded to 
porphyrin IX molecule and also two axial ligands(Shaik et al, 2004).The 
thiolate is one of the axial ligand derived from cysteine residues .The second 
ligand depends on the enzymatic reaction .But, originally water is bonded to the 
centre(Shaik et al, 2004). The valence shell of iron molecule contains i.e. two 4s 
electrons and in six electrons in 3d shell. The reaction of CYP occurs by 
converting the oxidation state of iron between Fe2+ and ferric Fe3+ (Lewis et al, 
Fig.2. Absorption Spectroscopy of CYP enzymes  
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1996).The ferric state is more stable form. So, CYP450 enzymes get reduced 
with gain of electrons. 
 
 
 
 
MECHANISM OF REACTION OF CYTOCHROMES: 
The Cytochrome P450 catalysesmonooxgenase type of reaction by adding of 
one atom of oxygen to the aliphatic group of the substrate which results to water 
due to reduction of other oxygen atom. 
                         RH + O2 + NADPH + H+ → ROH + H2O + NADP+ 
CYP1B1 is active in the metabolism of, benzo[a]pyrene and (7, 12-DMBA) 
(Hayes et al, 1996). 
ROLE OF CYTOCHROME P450 ENZYMES: 
CytochromeP450 enzyme   system   constitutes a super-family of heme-thiolate 
enzymes involving in the metabolism of exogenous molecules e.g. natural 
Fig.3. Structure of CYP450 enzymes 
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products, drugs, and carcinogens and endogenous compounds e.g. hormones. 
The human cytochromeP450 enzymes   are encoded by 57 genes and are 
divided into four classes. The Class I and Class II CYPs monooxygenases 
catalyzing a number of reactions such as conversion of alkenes to epoxides, 
alkanes to alcohols &arenes to phenols .(Sridhar et al, 2012) .The metabolism of 
carcinogens, procarcinogens, and chemotherapeutics by CYPs plays a important 
role in the cancer prevention and treatment strategies. Among all the different 
types of CYP 450 enzymes ,CYP1B1 was the mostly responsible  in converting 
benzo[a]pyrene to  7,8-diol, benzo[c]phenanthrene further to 3,4-dihydrodiol, 
which is  the precursors of the ultimate carcinogens.( Ioannides et al,2004). 
 
STRUCTURE OF CYTOCHROME P450 ENZYME AND THEIR BINDING 
SITES: 
The CYP1B1gene (Genbank accession no- U03688) is contained within 3 exons 
and 2 introns on chromosome 2p21 and spans 8.5 kb of genomic DNA.The 
catalytic domain consists of 543 amino acids which folds into a triangularprism 
shape (Fig.)(Sissung et al , 2006)additionally; there is a conserved sheet 
ofdomain near the N terminus of the protein. The number ofhelices is larger, but 
these helices are less conserved.Spatial conservation is largest for the structural 
core ofthe protein and diverges most for the substrate-binding site.Heme 
prosthetic group is the catalytic center of theenzyme.Most P450s are 
monooxygenases, and electrons for reductionof the heme and subsequently the 
oxygen substrate areprovided by protein partners that bind to the face of the 
proteinproximal to the heme.  There are major six microsomal P450s (1A1, 
1A2, 1B1,2E1, 3A4, and 2A6) which accountsfor most of the known 
carcinogenactivation pathways. Structures of 1B1 co-crystallized with 
theinhibitor alpha naphthoflavone (272 Da)(Wang et al, 2010).CYP1B1 are 
regulated by the Aryl hydrocarbon receptor. They are the Phase I reactions 
in drug metabolism. 
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alpha naphthoflavone
CYB1B1
 
 
 
 
 
 
 
 
 
CYP 
450 
family  
Human 
proteins 
Role in 
carcinogenesis 
Major 
characteristics 
of activated 
compounds 
Principal 
characteristics 
CYP1A 1A1,1A2 Very extensive PAH, AA, HA, MC, 
NNK, AAB 
Highly conserved; 
1A1 extra 
hepatic, 1A2 
hepatic 
TABLE 1.The table showed here reports all types of CYP450 enzymes 
responsible for bioactivation of PAH compounds 
FIG 4. CYP1B1 showing the inhibitor binding site i.e. alpha napthoflavone 
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ACTIVATION OF BENZO [A] PYRENE BY CYP 1B1: 
CYP1B1 is a unique enzyme that is expressed in many tumor types relative to 
normal tissue. It has the ability to activate a number of carcinogens in the 
chemical classes of PAHs, heterocyclic, aromatic amines, and nitro polycyclic 
hydrocarbons. Current studies has shown that CYP1B1 is involved in activation 
of environmental pro-carcinogen i.e. benzo [a]pyrene todiol epoxide which are 
carcinogen metabolites which forms DNA adducts. The first step in activation 
CYP1B 1B1 Very extensive PAH, AA, HA, MC, 
NNK, AAB, 
Oestrogens 
Over expressed in 
human tumors, 
skin cancer 
CYP2A 2A6, 2A7, 
2A13 
2A1, 2A2, 
2A3 
Moderate NA Species 
differences in 
substrate 
specificity. 
 
CYP2B 2B6 2B1, 
2B2, 2B3, 
2B12, 
2B15, 
2B16 
 
Moderate NA bioactivation of 
carcinogenesis 
CYP2C 2C8, 2C9, 
2C18, 
2C19 
 
Moderate Minor PAH Important role in 
drug metabolism 
CYP2D 2D6  Poor NNK Polymorphically 
expressed 
 
CYP2E  2E1 Extensive NA , HH Propensity to 
generate reactive 
oxygen species 
 
CYP3A 3A4, 3A5, 
3A7 
 
Moderate PAH,MC,PA Most 
important in drug 
metabolism 
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of benzo [a]pyrene is formation of BaP- 7, 8- epoxide. Then followed by 
hydrolysis of BaP- 7, 8-epoxide to (–) – benzo[a]pyrene -7R-Trans-7, 
8dihydrodiolmetabolite by microsomal epoxy hydrolase. This metabolite is 
further reacted by P450 to mutagenic benzo[a] pyrene-r-7, t-8-dihydrodiol-t-9, 
10-epoxide species which is also known as diol epoxide 2 (DE 2). DE 2 is 
extremely reactive species which can bind to DNA, RNA and protein. It is 
reported that the DE 2 forms DNA adducts in the p53 tumor suppressor gene. 
(Sutter et al, 1998) 
 
 
INHIBITION OF CYP1B1 BY A NATURAL DRUG i.e. TULSI: 
 Commonly known as Tulsi or Holy Basil in English 
 
Fig .5 Bioactivation of benzo[a]pyrene by CYP1B1 
Fig.6 BlackTulsi 
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Kingdom Plantae 
 
Divison- Magnoliophyta 
 
Class- Magnoliposida 
 
Order- Lamiales 
 
Family- Lamiaceae 
 
Genus- Ocimum 
 
Species- sanctum, tenuiflorum,gratissimum 
Tulsisymbolizes piousness. It is considered as the holy plant in the Indian 
tradition rituals. It is found in almost all Indian homes for religious and 
medicinal purposes. They are mainly consists of two types of different 
morphology as seen in fig .7 one is with purple leaved or darker in color 
commonly known as Shyama or Krishna Tulsi.Another one is green or light 
colored leaves known as Rama tulsi .A third type of tulsi is also known to be 
growing as a forest tulsi known as Vanatulsi.  
Table 2. Classification of the plant 
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TheTulsikavacham as described Tulsi as a protector of life of human-being till 
death (Dymock et al, 1993).So, the medicinal use of Tulsi is well  documented 
to long back. All the parts of Tulsi are known to have used for therapeutic 
purposes such as the juice of the leaf is used eye drop preparation it also treats 
from chronic fever,dysentery,dyspepsia and hemorrhage (Uma Devi et al, 
2001). The aqueous decoction of leaves of tulsi is given to patients suffering 
from gastric and hepatic disorders (Gupta et al, 2002).It is also used as a 
prophylactic against malaria with combination with black pepper. The seeds are 
reported to posses’anti-inflammatory, hypoglycemic, hypouricemic and 
uricosuricproperties. Experimentsof alcoholic and aqueous extract of tulsi ‘s 
leaves have the medicinal properties like antipyretic,analgesic, anti-
asthmatic,diaphoretic, hypotensive, hypolipidemiaand anti-stress etc.(Sarkar 
and Pant,1989).The oil extracted from Tulsi has anti-bacterialand anti-oxidant 
properties which is used in industry of skin cream formation.(Singh et al, 
2007).Tulsi due to its diversities of medicinal properties is known as Elixir of 
Life (Kumar et al ,2012).Cancer is the leading disease causing death world 
wide.Therefore all types of possible drugs from ethanobotany are experimented 
to show its anti-cancer properties. Tulsi was successfully documented as anti-
Fig 7.Two types of Tulsi: Krishna Tulsi& Rama Tulsi 
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cancer agent at non-toxic concentration(Uma Devi et al,2001).Several 
constituents of Tulsi reported as active compounds which behave as anti-cancer 
agent were Eugenol, Caryophyllene,Flavanoids,Linalool, 
Carvacrol&Elemene.Eugenol is the major active constituent along with others. 
These components found effective against inhibiting Cytochrome P450enzymes 
from binding benzo[a]pyrene. These compounds bind to Cytochrome P450 
inhibitory site. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
OBJECTIVES 
 Objective 1.   
Selection of inhibitor drugof cytochrome p450 
 
 Objective 2. 
Preparation of both dry powder and liquid extract of tulsi and study the 
cytotoxicity mediated by benzo [a]pyrene. 
 
 Objective 3.  
Studying the various in vitro studies of the inhibitor of cyp450 in HaCaT 
cells 
 MTT assay 
 DAPI staining 
 EROD  assay 
 
 Objective 4.  
 Confirming the inhibitor of the cyp450 by in silico approach   
  Finding the  ligands  and receptor ‘s  structure from Chem spider 
and protein data bank respectively 
 Studying the docking aspects of ligands with the receptor. 
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MATERIALS AND METHODS 
In this report, my objective is to inhibit the activity of Cytochrome enzymes 
using a certain natural drug as inhibitor. For this purpose I have 
chosenTulsi as a natural drug playing the role of inhibitor. 
 
SAMPLE COLLECTION: 
The leaves of Tulsi were collected from the local areas which were known as 
black Tulsi .The leaves were washed throughrouly and kept for drying for 4-5 
days at room temperature. 
PREPARATION OF AQUEOUS EXTRACT AND DRY POWDERED 
FORM: 
The sample was 14 gm in total. We distributed in two equal portions to prepare 
the extract and powder.  
Aqueous Extract 
 First dried leaves were weighed. 
 Then to it 5 ml of distill water was added and grinded by mortar and 
pestle finally 30 ml more water was added to make the final extract. 
 The paste was distributed equally two falcon tubes and centrifuged at 
12000 rpmat 4 ° C for 20 mins. 
 The supernatant was extracted and filtered by Whatman Paper and stored 
at  -20 ° C 
 
 
Dry Powdered  
 Leaves were dried in vacuum evaporator. 
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 The dried leaves were made to powdered form by mortar and 
pestle. 
 The powdered was grinded till it becomes finely grinded particles. 
 Kept at 4 degrees. 
In-vitro analysis: 
CELL CULTURE: 
 In this experiment we are using HaCaT cell lines which are immortal human 
keratinocytes .All cells were grown as adherent monolayer in DMEM 
(Dulbecco’s Modified Eagle Medium) supplemented with 10%v/v FBS (Fetal 
Bovine Serum) containing penicillin and streptomycin in a (5%) CO2 incubator 
set at 37°C.  
Procedure: 
Once cells were confluent to 80-90% in healthy condition, they need to be 
passaged using trypsin for experiments. Before adding 0.5ml of 0.25% trypsin, 
cells need to be washed with 1x PBS-EDTA for reducing the serum effect, then 
the cells will easily detach by keeping them in 37°Cincubator for 3-5 min. After 
all the cells are detached the trypsin effects are neutralized by adding 1ml of 
serum containing media and repeated pipetting the cell suspension. Then 
aspirate the flask solution and collect in the micro centrifuge tubes to spin down 
at 1000 - 2500 rpm for 4-5 min. The pelleted cells were re-suspended in 1 ml of 
fresh medium and equally distributed in flasks containing complete medium. 
When seeding for experiments, live cells were stained by Trypan blue and 
counted using a haemocytometer. 
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MTT ASSAY:  
It is a colorimetric assay for assessing viable cells. It measures the cell viability 
and proliferation in response to external factors  
Principle: 
 MTT -3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide is a 
yellow color reduced to purple formazan in the mitochondria of living cells. The 
absorbanceof this colored solution can be quantified by measuring at a certain 
wavelength (usually between 500 and 600 nm) by a spectrophotometer.This 
reductiontakes place only when  mitochondrial reductaseenzymes are active, 
and therefore conversion can be directly related to the number of viable (living) 
cells. The formazan product of the MTT Tetrazolium accumulates as insoluble 
precipitate .This product must be solubilized prior to the absorbance readings. It 
is solubilized by DMSO. 
Procedure: 
 The MTT stock solution was made 5mg/ml MTT in PBS Solution .Then 
filtered by 0.22 mm filter. 
 The HaCAT cells were seeded at the rate of 50000 cells/ml in 96 well 
plate for overnight incubation at 37°C and 5% CO2 in incubator. 
 The cells were treated at different concentrations of benzo[a]pyrene i.e. at 
0.5, 1, 2.5,5, 10 µM. 
 On 72 hrs20µl of MTT was added to each well and incubated for 4 hrs. 
 After 4hrs discard the media and 200 µl DMSO (Sigma) was added. 
 The reading was taken by ELISA Plate reader at 595nm (Perkin Elmer). 
 Similarly ,MTT with drug that is Tulsi + Benzo[a]pyrene  was done at 
various concentration of Tulsi (10,20,50,100µg concentration) 
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DAPI NUCLEAR STAINING:  
 DAPI (4', 6-diamidino-2-phenylindole) is a nuclear stain that binds strongly to 
minor groove at A-T rich regions in DNA. It is used to see the nuclear damage 
in fluorescence microscopy. When bound to DNA, it has an absorption 
maximum at a wavelength of 358 nm and its emission maximum is at 461 nm 
which is blue in color. It also binds to RNA 
 Drug treated preseededcells are treated with 4% paraformaldehyde  
 After 8 hrs exposure then washed with PBS.  
 Then  DAPI  stain  was  added  to  it  
 Incubated for 5 mins.  And observed under florescence microscope. 
 
EROD ASSAY: 
EROD (Ethoxyresorufin-0-deethylase) is a compound used to measure the 
activity of CYP450 enzyme (Klotz etal, 1984). This enzyme‘s activity converts 
ethoxyresorufin to resorufin  and the assay is well known as EROD assay.   
Steps: 
 The cells were seeded at 50000 cells /ml 
 Next day the cells reached the 70%  of confluence 
 Then drug i.e. tulsi was added in three different concentration 100 ,50 and 
10µg in each well 
 Add Benzo[a]Pyrene at concentrations 5,2.5 and 1µM   
 Also add Tulsi and benzo[a]pyrene at concentration 100µg,5µM  ,another 
50µg,2.5µM and 10µg,1µM respectively indifferent wells 
 Then the cells are washed with PBS and 100µL of EthoxyResorufurin 
was added. 
 Reading was taken at 530 nm wavelength by Elisa plate reader. 
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The Extract of Tulsi is checked for the presence of active compounds by 
performing TLC (Thin Layer Chromatography) 
Thin layer Chromatography (TLC) 
It is a type of  chromatographic process of separation of  non-volatile mixtures 
of a sample (Lewis et al ,1989).It is done on glass, plasticor aluminum foil 
coated with silica gel ,cellulose and other material which act as adsorbent 
material.After putting the sample from 1.5 cm above from the edge of the 
bottom of the foil, the sample runs upwards because of capillary action due to 
different components present in t at different separation rate. 
Steps: 
 The dry powder of 1mg Tulsi was dissolved in  500µl methanol 
 And dried in vacuum evaporated  
 Place the silica gel foil in 3ml of n-Hexane and 7 ml of ethyl 
acetate. 
 Then TLC  was done  
 Then  it is seen under UV  
Further to confirm presence of other components, NMR was performed. 
 
In-silico Approach: 
For our in-silico approach we have use various bioinformatics tools like Chem 
Spider, PDB (Protein Data Bank and software’s like Chimera, Open Babel, 
Hex6.3 and Ligplus.  
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STEP .1 
In the first step structures of active compounds structure i.e. ligand structure 
files of eugenol, linalool, caryophyllene, carvacrol and elemene are retrieved 
from Chem spider.  
CHEM SPIDER  
Chem Spider is a chemistry database which is owned by the Royal Society of 
Chemistry and includes chemical information of more than 25 million 
compounds. It includes images of structures of 2D, 3D and articles (Pub med, 
Google books, scholar and journals).Every compound is denoted by individual 
identifiers (CAS Registry Number, InCHl.) The properties of those chemicals 
are also included. We have basically three types of searches- simple search, 
structure search and advanced search. 
Steps:  
 First entered the name of the ligands in the structure and simple search 
icons. 
 Then the compound information page will appear which will consists of 
general name of the compound, Chem spider ID, molecular formula, 
monoisotopic mass, systematic chemical name and structure both in 2D 
& 3D. 
 So, we can download the structures. 
STEP.2  
These structures which are retrieved are in molecular files (mol files). We have 
to convert those structures in PDB visualization. Software called Open Babel 
which helps in converting these mol files to pdb format  
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OPEN BABEL 
It is a free and open source version of the Babel Chemistry File translation 
program. It is a project designed to interconvert between many file formats used 
in docking and molecular modeling. 
Steps: 
 
 We have selected the input file from the list after opening the software. 
 Selected the file and the file format is displayed in the text box. 
 We have selected the output format as .pdb 
 Click on the Convert icon  
 Save the file. 
 
STEP.3 
The receptor enzyme structure of cytochromeP450 is retrieved from PDB ID: 
3PMO  
PROTEIN DATA BANK (PDB) 
The PDB (Protein Data Bank) is the worldwide archive of Structural data of 
Biological macromolecules, established in Brookhaven National Laboratories 
(BNL). It contains Structural information of the macromolecules determined by 
X-ray crystallographic, NMR methods etc. RASMOL [Raster Display of 
Molecules] is a molecular graphics program intended for the structural 
visualization of proteins, nucleic acids and small biomolecules. The program 
reads in molecular coordinate files and interactively displays the molecule on 
the screen in variety of representations and color schemes. All protein structure 
is retrieved from protein data bank and further applies for docking. 
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STEP .4 
In this step the pdb file of CYP1B1 is obtained and it is bind to an inorganic 
inhibitor alpha –Napthoflavone.  As we know alpha Napthoflavone is the 
inhibitor of CYP1B1(Wang et al , 2010) .For our studies we have to remove this 
inhibitor from the structure because we have to prove whether the active 
compounds of Tulsi act as inhibitor to CYP1B1.Therefore we used a software  
named Chimera for removing the inhibitor alpha - Napthoflavone . 
 
UCSF Chimera 1.6.2- 
UCSF chimera is highly  extensible  program  for  interactive  visualisation  and  
analysis  of  molecular  structure  and  related  data,  including  density  map,  
supra molecular  assembly,  sequence  alignment,  docking  results,  trajectories  
and  conformational  ensembles.  Chimera is highly extensible program for 
interactive visualization and analysis of molecular structures. 
Steps: 
  Inhibitor Ligand i.e.ANF  is selected  
 Ligand is removed  
 
STEP.5 
As we have removed the inhibitor ligand which was present in the active cavity 
of CYP1B1, the structure of CYP1B1 may be distorted and unstable. Hence the 
Software Swiss Pdb Viewer is used to repair the distorted geometries through 
energy minimization. In this implementation, all computations are done in 
vacuum, without reaction field 
 
SWISS PDB VIEWER (SPDV) 
Swiss pdb viewer is the software used to mutate the amino acid residue in the 
chain, showing the various bonds present in the structure, changing the 
orientations and energy minimizations etc. 
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STEP .6 
Docking  
Docking is done by Hex 6.2 software which is an interactive molecular graphics 
program for calculating and viewing feasible docking models with Evalue. 
HEX 6.3 
 Hex is an Interactive Molecular Graphics Program for calculating and 
displaying feasible docking modes of pairs of protein and DNA molecules. Hex 
6.3 can also calculate Protein-Ligand Docking, assuming the ligand is rigid, and 
it can superpose pairs of molecules using only knowledge of their 3D shapes .It  
uses Spherical  Polar  Fourier  (SPF)correlations to accelerate  the calculations 
and its one of the few docking programs which has built in graphics to view the  
result. 
Steps: 
 Go to file menu and Open the Receptor CYP1B1 
 Again go to file menu and open ligand like eugenol.pdb, similarly other 
active compounds also in next docking process. 
 We have to check the docking criteria of the both protein and the ligand 
.So, we have to fix various parameters.Then go to Control menu and 
adjust the SPF Transform, FFT steric scan, FFT final search ,MM 
refinement and finally FTR value  
 Click for docking  
 
STEP.7 
After docking, the residual binding is analyzed by Ligplus software whether to 
check various interactions of the molecules. Interaction like hydrophobic, 
hydrogen bonding and vanderwaals forces are exerted on the residual binding. 
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LIGPLOT: 
The active compounds bonded to the active sites or not were checked by this 
software. Then the active compounds were made to bind with benzo[a]pyrene. 
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RESULT AND DISCUSSION 
 
1. In- vitro studies: 
Since from in-silico studies it is confirmed that the compounds of Tulsi binds to 
CYP1B1.So by performing these in- vitro experiments MTT assay, DAPI and 
EROD assay we can confirm our objectives. 
1.1 MTT ASSAY 
a) Cells were treated with benzo[a]pyrene, and then cell viability was measured 
by MTT assay. B[a]P reduces the viability of HaCaT cells at indicated 
concentrations.Also in same plate the Tulsi were also added with B[a]P at 
indicated concentrations. The graph shows that Tulsi inhibits the cytotoxicity 
caused by Benzo[a]pyrene at dose dependent manner. From the figure below we 
concluded that lowest cell viability is seen when HaCaT Cells are treated with 
5µM concentration of Benzo[a] Pyrene. 
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                                                    →Concentration of B[a]P 
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Fig no.8 The decrease in cell viability by increase in the concentration of B[a]P. 
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b)  
 
 
Concentration of B[a]P 
 
 
 
In the second MTT assay, it is performed on two aspects one is in the cells that 
are treated with B[a]Pand other aspect when cells are treated to B[a]P +Tulsi. It 
shows increase in cell viability upon treatment to Tulsi .Hence it confirms to 
inhibit cytotoxicity. 
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Fig no.9  It shows the comparison between cell viability when the cells are treated 
with B[a]P and B[a]P+Tulsi. 
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1.2 DAPI STAINING 
In control we can see no DNA fragmentation was observed. As from the figure 
it is confirmed that at higher concentration of benzo[a]pyrene 5µM, DNA 
fragmentation and also membrane blebbing is observed. The dose dependent 
effect can be observed in the cells. 
 
 
 
 
 
 
 
 
 
 
Fig. no.10  NoDNA damage is present on treatment with Tulsiand in 
B[a] P treated cells nuclear damage and membrane blebbing occurred 
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1.3 EROD ASSAY 
The conversion of ethoxyresorufurin into resorufurin by liver enzymes confirms 
the activity of CYP450 enzymes. From this adding EROD to benzo[a]pyrene 
increases the activity of CYP450 enzymes. But, the EROD when added to Tulsi 
at different concentration normalize the activity of CYP450 enzymes .The Tulsi 
hence suppress the activity of CYP450 enzymes when added in combination of 
B[a] P at distinct differences shown from that of only B[a] P. 
 
 
 
1.4. FROM TLC AND NMR: 
The results of Thin Layer Chromatography was distinct four bands were seen 
clearly. From other sources it is confirmed that eugenol ,caryophyllene at R.F 
values of 0.7 giving orange brown and reddish violet color respectively.( 
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Fig no. 11 – The activity of cytochrome P450 enzymes on increasing  
Benzo[a]pyrene,Tulsi&Benzo[a]pyrene +Tulsi. 
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Referred From HCMS ) Other bands were not identified .So , to further confirm 
the structures NMR Spectroscopy  was done.  The below mentioned figure is 
the NMR of Tulsi extract.  
 
 
 
 
2. Insilco Analysis: 
2.1 CHEM SPIDER: 
The structures which were retrieved from Chem spider of the active compounds 
of Tulsi: It consists of the Chem spider ID, Systematic name, molecular formula 
and structure. 
 
Fig no.12   The NMR Spectroscopy of Tulsi showing various constituents. 
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Constituents of Tulsi 
(chem. spider ID) 
Systematic name 
Molecular 
formula 
Structure 
 
 
Eugenol, 13876103 
 
 [4-Allyl-2-methoxyphenol ] 
 
 
 
 
 
C10H12O2 
 
 
 
 
 
 
Caryophyllene,4444848 
 
[(1R,4E,9S)-4,11,11-Trimethyl-
8methylenebicyclo[7.2.0]undec-
4-ene ] 
 
 
 
 
 
C15H24 
 
 
 
 
Elemene ,10138 
 
[ 2,4-Diisopropenyl-1-methyl-
1-vinylcyclohexane ] 
 
 
 
 
 
 
C15H24 
 
 
 
 
 
 
Carvacrol,21105867 
 
[ 5-Isopropyl-2-methylphenol ] 
 
 
 
C10H14O 
 
 
TABLE NO.3 - Structures of active compounds retrieved from Chem spider 
35 
 
 
2.2 OPEN BABEL:  
The above structures are converted to pdb format because the docking process 
would not understand the format of mol files. 
2.3 PROTEIN DATA BANK: 
The receptor Cytochrome 450 enzyme i.e. CYP1B1 structure was retrieved 
from PDB. 
 
 
Linalool ,13849981 
 
[ 3,7-Dimethyl-1,6-octadien-3-
ol ] 
 
 
 
 
C10H18O 
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2.4 UCSF CHIMERA:  
The inhibitor alpha Napthoflavone was removed from the structure of 
CYP1B1.So that our active compounds can bind with CYP1B1. 
 
 
 
 
 
Fig no. 13 The structure of CYP1B1 with its inhibitor Alpha Napthoflavone from 
PDB. 
37 
 
2.5 SWISS PDB VIEWER:  
After removal of the structure of inhibitor present n CYP1B1, the structure was 
distorted. Hence the energy minimization was done by Swiss pdb viewer. The 
energy we get is -25794.668 KJ/MOL. 
2.6 DOCKING STUDIES: 
The activation of the CYP1B1 results in bonding to the active compounds of 
Tulsi. The high negative energies got through the docking with help of Hex 6.3 
were confirmed that stable bonding at active sites. Further by software i.e. Lig 
plot, we confirmed that  the active compounds  of Tulsi do not bind to active 
sites of benzo[a]pyrene rather got bonded to non-specific binding. The table 
below shows the energies value of the binding with CYP1B1:                                                      
A) 
 
Fig no.14  docking with eugenol and CYP1B1 
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B) 
CYP450-CARYOPHYLLENE COMPLEX 
 
 
 
 
 
 
 
 
 
Fig no. 15 docking withcaryophylleneand CYP1B1 
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C)   
CYP450-CARVACROL COMPLEX 
 
 
 
 
 
 
 
Fig no.16  docking withcarvacrol and CYP1B1 
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(D) 
 
CYP450-LlNANOOL COMPLEX 
 
 
 
 
 
 
 
Fig no 17   docking with linalool and CYP1B1 
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(E) 
CYP450-ELEMENE COMPLEX 
 
 
 
 
 
 
 
 
 
Fig no. 18 docking withelemene and CYP1B1 
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CONSTITUENTS OF TULSI 
(CHEM. SPIDER ID) 
 
 
BINDING ENERGIES 
WITH CYP (DOCKING E 
VALUE)KCAL/MOL 
 
 
 
EUGENOL , 13876103 
 
 
 
 
-174.48 
 
 
CARYOPHYLLENE ,4444848 
 
 
 
 
-189.60 
 
 
ELEMENE ,10138 
 
 
 
 
-193.68 
 
 
CARVACROL ,21105867 
 
 
 
 
-165.5 
Table no. 3 the energies value of the binding with CYP1B1 
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Ligand Protein Interactions by LIG PLUS:  
 
 
 
 
Fig.  19 Ligand protein interactions of caryophyllene 
Fig.20 Ligand protein interaction of Linalool 
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Fig. 21 Ligand protein interaction of carvacrol 
Fig. 22 Ligand protein interaction of Elemene 
45 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fig. 23 Ligand protein interaction ofeugenol 
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CONCLUSION 
From the above work, we have concluded that Benzo[a]pyrene causes 
cytotoxicity in HaCaT cells by DNA fragmentation and membrane blebbing 
through the DAPI experiments. Benzo[a] Pyrene causing cytotoxicity can be 
minimized by inhibiting CytochromeP450 enzymes. These enzymes are 
inhibited from binding to B[a]P by a natural drug Black Tulsi. It consists of 
many flavanoids, fatty acids, proteins and oils among all five major compounds 
confirmed from TLC and NMR that are present abundantly. They are eugenol, 
caryophyllene, carvacrol, elemene and Linalool .The active compounds present 
in Tulsi have shown high negative binding energies with CYP450 enzymes 
through docking studies. Tulsi unlike alpha naphthoflavone is more natural and 
free from side effects. Hence Tulsi can acts as powerful inhibitor towards 
CYP450 enzymes. From EROD assay it is confirmed that Tulsi inhibits 
CYP450 activity in general not specifically CYP1B1. MTT assay has also 
shown that the cells show more viability towards Tulsi’s extract rather than 
benzo[a]pyrene. From our studies it shows all the active compounds like 
eugenol, caryophyllene, elemene, carvacrol and linalool have high reaction 
affinity to CYP450 enzymes.Interestingly, Tulsi has been evaluated inhibitor for 
Cytochrome P450 demonstrating blocking the activation of 
Benzo[a]pyrenewhich could have therapeutic benefits from several diseases 
including allergy and cancer. 
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